These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2396472)

  • 1. Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. I. Efficacy and analysis of vaccine failures.
    Fescharek R; Quast U; Maass G; Merkle W; Schwarz S
    Vaccine; 1990 Aug; 8(4):333-6. PubMed ID: 2396472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects.
    Fescharek R; Quast U; Maass G; Merkle W; Schwarz S
    Vaccine; 1990 Oct; 8(5):446-56. PubMed ID: 2251871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Side effects of the use of the preventive mixed mumps, rubella and measles vaccine inchildren of the City of São Paulo].
    Konichi SR; Laus WC; Mattos CA; Amato Neto V; Aly J; Finger H; Bianchi A
    Rev Inst Med Trop Sao Paulo; 1973; 15(3):161-4. PubMed ID: 4732747
    [No Abstract]   [Full Text] [Related]  

  • 5. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMR vaccination, measles epidemiology and sero-surveillance in the Republic of Ireland.
    Johnson H; Hillary IB; McQuoid G; Gilmer BA
    Vaccine; 1995 Apr; 13(6):533-7. PubMed ID: 7483773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measles-mumps-rubella vaccination program in Finland.
    Lerman SJ
    N Engl J Med; 1995 Apr; 332(16):1103. PubMed ID: 7898541
    [No Abstract]   [Full Text] [Related]  

  • 10. Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986-94. Sentinella Arbeitsgemeinschaft.
    Matter HC; Cloetta J; Zimmermann H
    J Epidemiol Community Health; 1995 Aug; 49 Suppl 1(Suppl 1):4-8. PubMed ID: 7561669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 12. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aseptic meningitis after measles, mumps, and rubella vaccine.
    Tesović G; Begovac J; Baće A
    Lancet; 1993 Jun; 341(8859):1541. PubMed ID: 8099418
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles, MMR, and autism: the confusion continues.
    Lancet; 2000 Apr; 355(9213):1379. PubMed ID: 10791514
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children.
    Miller E; Goldacre M; Pugh S; Colville A; Farrington P; Flower A; Nash J; MacFarlane L; Tettmar R
    Lancet; 1993 Apr; 341(8851):979-82. PubMed ID: 8096942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mumps meningitis after mumps, measles, and rubella vaccination.
    Gray JA; Burns SM
    BMJ; 1989 Dec; 299(6713):1464-5. PubMed ID: 2514842
    [No Abstract]   [Full Text] [Related]  

  • 18. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
    MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases.
    Vaccine; 1998 May; 16(8):818-22. PubMed ID: 9627939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain and measles, mumps, and rubella vaccination.
    Lyons R; Howell F
    Arch Dis Child; 1991 Mar; 66(3):346-7. PubMed ID: 2025015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.